Page last updated: 2024-08-16

sb 239063 and gadolinium dtpa

sb 239063 has been researched along with gadolinium dtpa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, DF; Boyce, RW; Jucker, BM; Lenhard, SC; Mirabile, RC; Nerurkar, SS; Schaeffer, TR; Willette, RN	1

Other Studies

1 other study(ies) available for sb 239063 and gadolinium dtpa

Article	Year
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:3 Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium DTPA; Glomerular Filtration Rate; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Magnetic Resonance Imaging; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred SHR; Sodium, Dietary; Stroke	2003

Article

Year

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.

The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:3

Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium DTPA; Glomerular Filtration Rate; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Magnetic Resonance Imaging; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred SHR; Sodium, Dietary; Stroke

2003